Paper Review Records
All Paper Review Records
11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Cerebral microhemorrhage and cognition in preclinical Alzheimer’s disease
Dobri Baldaranov; Shunran Wang; Rema Raman; Karin Ernstrom; Kejal Kantarci; Clifford R. Jack; Reisa A Sperling; Paul S Aisen; Michael S RafiiShow moreShow less
Epstein Family Alzheimer’s Therapeutic Research Keck School of Medicine, University of Southern California, San Diego, CA, 90033, USA; Departments of Neurology, Massachusetts General Hospital, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USAShow moreShow less
Is it time to make brain health a vital sign?
Gregory CooperShow moreShow less
Norton Healthcare, Kentucky, United StatesShow moreShow less
MIND GamePack: A novel digital health technology for assessment of participants with and without cognitive impairment
Jake A. Galler; Liuqing Yang; Chao-Yi Wu; Cathrine Young; Edmarie Guzmán-Vélez; Katherine W. Cropp; Anthony W. Bannon; Hiroko H. Dodge; Jessica A. Gerber; Steven E. ArnoldShow moreShow less
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, United States; AbbVie Inc., 1 Waukegan Rd., North Chicago, IL, 60064, United States; Department of Neurology, Rutgers Robert Wood Johnson Medical School, 112 Paterson Street, New Brunswick, NJ, 08901, United StatesShow moreShow less
Sex differences in subjective cognition among middle-aged and older Hispanic/Latino adults: Findings from the HCHS/SOL and SOL-INCA
Ariana M. Stickel; Wassim Tarraf; Sayaka Kuwayama; Ammie Xie; Rachel Membreno; Carolina L. Costa; Carlos E.E. Araujo Menendez; Zvinka Z. Zlatar; Krista M. Perreira; Haibo Zhou; Martha Daviglus; Amber Pirzada; Paola Filigrana; Bonnie E. Levin; Linda C. Gallo; Hector M. González; Sarah J. BanksShow moreShow less
Department of Psychology, San Diego State University, San Diego, CA, USA; Institute of Gerontology & Department of Healthcare Sciences, Wayne State University, Detroit, MI, USA; Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Department of Psychological & Brain Sciences, Washington University in St. Louis, St. Louis, MO, USA; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA; Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA; Department of Social Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Department of Biostatistics, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA; Institute for Minority Health Research, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Neurology, University of Miami, School of Medicine, Miami, FL, USAShow moreShow less
Tau-ing and fro-ing: the tanycytic shuttle in neurodegeneration
Vincent Prévot; Markus Schwaninger; Ruben Nogueiras; S. RasikaShow moreShow less
Univ. Lille, Inserm, CHU Lille, Lille Neuroendocrinology, Lille Neuroscience & Cognition, UMR_S 1172, 59000 Lille, France; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany; CIMUS, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, SpainShow moreShow less
Drawing a line: Differentiating mild from moderate dementia using the functional activities questionnaire
Ersin Ersözlü; Lukas Preis; Aykut Aktuz; Louise Droste; Akin Erman; Daria Gref; Katharina Sophie Strentz; Julian Hellmann-RegenShow moreShow less
Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Psychiatry and Neurosciences, Hindenburgdamm 30, 12203, Berlin, Germany; Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, ECRC Experimental and Clinical Research Center, Lindenberger Weg 80, 13125, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Berlin, Germany; Maastricht University, Faculty of Psychology and Neuroscience, Maastricht, the NetherlandsShow moreShow less
FAQ
How long does JPAD-Journal of Prevention of Alzheimers Disease take to review a manuscript?
As of 2026-11-19, CrushSCI has 11 complete review records for JPAD-Journal of Prevention of Alzheimers Disease. The fastest paper went from submission to acceptance in 1 days (Is it time to make brain health a vital sign?, received 2026-08-04, accepted 2026-08-05); the slowest took 159 days. The average is 80.4 days and the median is 87 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
